instance evaluation process years assuming drug candidate successful tests enters phase 1 phase 2 finally phase 3 clinical trials humans fda establishes number patients required phase clinical trials according guidelines based disease treated example drug candidate disease afflicts 10,000 people smaller number patients trials potential drug fight disease afflicts millions high blood pressure end clinical trials company presents data fda decides not approve drug sale public average cost developing new drug excess $ 1 billion takes 10 years wide discrepancy estimates actual cost time required attempted provide unbiased estimate variety sources patents typically granted initial research phase investigation company developing